Re-emergence of yellow fever in Senegal in 1995

American Journal of Tropical Medicine and Hygiene

Volumn 59, Issue 1, 1998, Pages 108-114

  Thonnon, Jocelyn ^a   Fontenille, Didier ^b   Tall, Adama ^a   Diallo, Mawlouth ^a   Renaudineau, Yves ^a   Baudez, Bertrand ^a   Raphenon, Georges ^a  

^a INSTITUT PASTEUR DE DAKAR   (Senegal)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

Author keywords

[No Author keywords available]

Indexed keywords

YELLOW FEVER VACCINE;

ADOLESCENT; ADULT; AEDES AEGYPTI; AGE DISTRIBUTION; AGED; ARTICLE; CASE FINDING; CHILD; CLINICAL ARTICLE; DISEASE CONTROL; DISEASE TRANSMISSION; EPIDEMIC; FATALITY; FEMALE; HUMAN; IMMUNIZATION; INFANT; MALE; NEWBORN; SENEGAL; VIRUS ISOLATION; YELLOW FEVER; YELLOW FEVER FLAVIVIRUS;

EID: 0031746083     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1998.59.108     Document Type: Article

References (26)

1. Rice CM, Lenches SR, Edy SR, Shin SJ, Sheets LR, Strauss JH, 1985. Nucleotide sequence of yellow fever virus. Implications for flavivirus gene expression and evolution. Science 229: 726-733.
2. Monath TP, 1989. Yellow fever. Monath TP, ed. The Arboviruses: Epidemiology and Ecology. Volume 5. Boca Raton, FL: CRC Press, 139-231.
3. Digoutte JP, Cornet K, Deubel V, Downs WG, 1995. Yellow fever. Porterfield J, ed. Exotic Virus Infections. London: Chapman & Hall, 67-102.
4. Robertson SE, Hull BP, Tomori O, Bale O, Leduc JW, Esteves K, 1996. Yellow fever, a decade of reemergence. JAMA 276: 1157-1161.
5. WHO, 1996. Yellow fever in 1994 and 1995. Wkly Epidemiol Rec 71: 313-320.
6. Robin Y, Bres P, Henderson BE, William KH, 1967. Une épidémie de fièvre jaune au Sénégal en 1965. Virol Bull World Health Organ 36: 119-150.
7. Monath TP, Craven RB, Adjukiewicz A, Germain K, Francy DB, Ferrara L, Samba EM, N'Jie H, Cham K, Fitzgerald SA, Crippen PH, Simpson DIH, Bowen EIW, Fabiyi A, Salaun JJ, 1980. Yellow fever in the Gambia 1978-1979. Epidemiological aspects with observations on the occurrence of Orungo virus infections. Am J Trop Med Hyg 29: 912-928.
8. Digoutte JP, Plassart H, Salaun J, Heme G, Ferrara L, Germain M, 1981. A propos de 3 cas de fièvre jaune au Sénégal. Bull World Health Organ 59: 759-766.
9. Digoutte JP, Calvo-Wilson MA, Mondo K Traore-Lamizana M, Adam F, 1992. Continuous cell lines and immune ascitic fluid pools in arbovirus detection. Res Virol 43: 417-422.
10. Schlessinger JJ, Brandriss MW, Monath TP, 1983. Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever by neutralization, hemagglutination inhibition and immune precipitation of the virus envelope protein. Virology 125: 8-17.
11. Casey HL, 1969. Standardized Diagnostic Complement Fixation Method and Adaptation to Microtest. Public Health Monograph no. 74. Washington, DC: U.S. Government Printing Office.
12. Lhuillier K, Sarthou JL, 1983. Intérêt des IgM antiamariles dans le diagnostic et la surveillance épidémiologique de la fièvre jaune. Ann Virol Inst Past 134E: 349-359.
13. De Madrid AT, Porterfield JS, 1969. A simple microculture method for the study of group B arboviruses. Bull World Health Organ 40: 113-124.
14. Cornet M, Yan C, Coz J, 1977. Place de l'homme dans les cycles épidémiologiques de la fièvre jaune en Afrique de l'Ouest. Med Trop 37: 265-268.
15. Cordellier R, 1991. Epidémiologie de la fièvre jaune en Afrique de l'Ouest. Bull World Health Organ 69: 73-84.
16. WHO, 1986. Prevention and Control of Yellow Fever in Africa. Geneva: World Health Organization.
17. Baudon D, Robert V, Roux J, Lhuillier M, Saluzzo JF, Sarthou JI, Comet M, Stranghellini H, Gazin P, Molez JF, Some L, Darriet F, Soudret BR, Guiguemde TR, Hennequin M, 1986. L'épidémie de fièvre jaune au Burkina Faso en 1983, Bull World Health Organ 64: 873-882.
18. Aitken TH, Tesh RB, Beaty BJ, Rosen L, 1979. Transovarial transmission of yellow fever by mosquitoes (Aedes aegypti). Am J Trop Med Hyg 28: 119-121.
19. Fontenille D, Diallo M, Mondo M, N'Diaye M, Thonnon J, 1997. First evidence of natural vertical transmission of yellow fever virus in Aedes aegypti its epidemic vector. Trans R Soc Med Hyg 91: 533-535.
20. Saluzzo JF, Sarthou JL, Cornet M, Digoutte JP, Monath TP, 1986. Intérêt du titrage par ELIS A des IgM spécifiques pour le diagnostic et la surveillance de la circulation selvatique des flavivirus en Afrique. Ann Virol Inst Past 137E: 155-170.
21. Monath TP, Nasidi A, 1993. Should yellow fever vaccine be included in the Expanded Program of Immunization in Africa? A cost effectiveness analysis for Nigeria. Am J Trop Med Hyg 48: 274-299.
22. Traore-Lamizana M, Fontenille D, Zeller HD, Mondo M, Diallo M, Adam F, Eyraud M, Maiga A, Digoutte JP, 1996. Surveillance for yellow fever virus in eastern Senegal during 1993. J Med Entomol 33: 760-765.
23. WHO, 1994. Yellow fever surveillance in West Africa. Wkly Epidemiol Rec 69: 93-100.
24. Monath TP, 1994, Yellow fever and dengue, the interactions of virus, vector and hosts in the re-emergence of epidemic disease. Semin Virol 5: 133-145.
25. Lepinec L, Dalgamo L, Vû Thi QH, Monath P, Digoutte JP, Deubel V, 1994. Geographic distribution and evolution of yellow fever viruses based on direct sequencing of genomic cDNA fragments. J Gen Virol 75: 417-423.
26. Wang E, Weaver SC, Shope RE, Tesh RB, Watts DM, Barett ADT, 1996. Genetic variation in yellow fever virus: duplication in the 3' non coding region of strains from Africa. Virology 225: 274-281.